Money Talks: Profits Before Patient Safety

  • More Options

GD Star Rating
a WordPress rating system
Is This Documentary Broken?
(Click Here To Let Us Know)

Money Talks exposes the questionable tactics that big drug companies use to make record profits by playing with the safety of our family’s health care. Using misleading advertising, attractive “drug reps” who wine and dine doctors and other unethical practices, the drug industry makes billions of dollars every year selling us unsafe, unnecessary and overpriced drugs. If you want to protect the people you love from their dangerous practices that compromise the safety and quality of our health care, Money Talks is a must-see film.

Money Talks: Profits Before Patient Safety, 9.7 out of 10 based on 27 ratings

Related Documentaries

From The Web

  • Jmiller6

    Sales is sales. If a product is on the market, of course the company will do whatever it takes to make the sale. Welcome to capitalism. Drug development is expensive and in order to make new therapies in the future, they need revenue. If a drug is unsafe for use, it is the fault of the US Government agency, the FDA, for even approving it. 

  • R.W

    Thanks for today’s laugh, Jmiller6! It’s appreciated that there’s still peoples out there with a good sense of humour like you.

    But still you could of ended it with “/sarc.” so you don’t fool somebody that you would be serious with that comment.

    • Ruth

      I’m fairly sure Jmiller6 meant that Drug companies act like this because they are businesses looking to make a profit and not moral organisations, not that this situation is ideal.
      If we want to have a system where the prescribed drugs are the safest for any particular illness, then we need to stop relying on the people who stand the most to gain from the incorrect use of drugs to regulate this system. The best way to do this is surely to ensure that there are independent bodies such as the WHO, NICE or FDA who can take a clear and unbiased view of the whole situation, hopefully without being affected by the major drug companies.